Targeting CD38 by isatuximab and a CD38/CD3xCD28 trispecific T-cell engager in old patients with acute myeloid leukemia

Esperanza Martin-Sanchez  1 , Laura Blanco Fernández  2 , Peter S Kim  3 , Kamlesh Bisht  3 , Hongfang Wang  3 , Helgi Van de Velde  3 , Tomas Jelinek  4 , Catia Simoes  5 , Felipe Prosper  6 , Jesús F San-Miguel  7 , Ana Alfonso  8 , Juan Miguel Bergua Burgues  9 , Rebeca Rodríguez-Veiga  10 , Susana Vives  11 , David Martínez-Cuadrón  10 , Pau Montesinos  12 , Bruno Paiva  13 , Aintzane Zabaleta  14